Understanding cancer resistance to chemotherapy

Research area

 |  drug targets


 |  chemotherapy, cancer treatment, drug targets, screen, genetics


 |  PhD/Doctorate, Honours, Masters

Contact supervisors at any time

Professor Ron Firestein
e: ron.firestein@hudson.org.au

Project description

The majority of cancers initially respond very well to standard of care chemotherapeutics but invariably become resistant leading to cancer relapse and patient mortality. This project seeks to identify novel therapeutic targets that will synergise resensitize tumours to chemotherapies in the resistant setting.